| scholarly article | Q13442814 |
| P50 | author | Helena Kuivaniemi | Q42067412 |
| P2093 | author name string | Vaheri A | |
| Kivirikko KI | |||
| Korhonen RM | |||
| P2860 | cites work | Biosynthesis of Collagen Crosslinks: Increased Activity of Purified Lysyl Oxidase with Reconstituted Collagen Fibrils | Q35119840 |
| Decrease in the levels of nuclear RNA precursors for alpha 2 collagen in Rous sarcoma virus transformed fibroblasts | Q35702448 | ||
| Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: Fibronectin and procollagen | Q35995276 | ||
| Abnormal copper metabolism and deficient lysyl oxidase activity in a heritable connective tissue disorder. | Q37009011 | ||
| Alterations of post-translational modifications of procollagen by SV40-transformed human fibroblasts | Q40123316 | ||
| Pericellular matrix in malignant transformation. | Q40135379 | ||
| Reduced lysyl oxidase activity in skin fibroblasts from patients with Menkes' syndrome | Q41531865 | ||
| Regulation of proline 3-hydroxylation and prolyl 3-hydroxylase and 4-hydroxylase activities in transformed cells | Q42875294 | ||
| Posttranslational modifications in the biosynthesis of type IV collagen by a human tumor cell line | Q44473185 | ||
| Regulation of collagen post-translational modification in transformed human and chick-embryo cells | Q46592424 | ||
| Alterations in copper and collagen metabolism in Menkes' syndrome and a new subtype of Ehlers-Danlos syndrome | Q48703844 | ||
| Extracellular matrix proteins characterize human tumor cell lines | Q57382513 | ||
| The production of lysyl oxidase by human fibroblasts in culture | Q68640189 | ||
| Measurement of medium lysyl oxidase activity in aorta smooth muscle cells. Effects of multiple medium changes and inhibition of protein synthesis | Q72491979 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 261-264 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Deficient production of lysyl oxidase in cultures of malignantly transformed human cells. | |
| P478 | volume | 195 |
| Q38237959 | A new role for LOX and LOXL2 proteins in transcription regulation |
| Q34147808 | Amine oxidases and galactose oxidase |
| Q40642135 | Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts |
| Q24291077 | Cloning and characterization of a fourth human lysyl oxidase isoenzyme |
| Q71377772 | Detection of lysyl oxidase gene expression in rat skin during wound healing |
| Q78244545 | Differentially expressed genes associated with the metastatic phenotype in breast cancer |
| Q36259191 | Diverse biological functions of extracellular collagen processing enzymes |
| Q38563638 | EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma. |
| Q41244027 | Functional analysis of the promoter and first intron of the human lysyl oxidase gene |
| Q47584936 | Functional importance of lysyl oxidase family propeptide regions |
| Q38177145 | Human copper-dependent amine oxidases. |
| Q45996355 | Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. |
| Q70827305 | Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan |
| Q36792805 | Isolation and characterization of a 1 Mb region of 5q23.3-q31.2 surrounding the human lysyl oxidase gene |
| Q36709638 | Localization and activity of lysyl oxidase within nuclei of fibrogenic cells |
| Q58620548 | Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter |
| Q38723997 | Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer |
| Q35764623 | Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma |
| Q34784159 | Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. |
| Q34764399 | Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells |
| Q39825713 | Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. |
| Q37812321 | Lysyl oxidase: a potential target for cancer therapy |
| Q40616905 | Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis |
| Q34462312 | Lysyl oxidase: properties, regulation and multiple functions in biology |
| Q28201099 | Lysyl oxidases: a novel multifunctional amine oxidase family |
| Q48948039 | Micro-injection of recombinant lysyl oxidase blocks oncogenic p21-Ha-Ras and progesterone effects on Xenopus laevis oocyte maturation |
| Q43968121 | PKC-MEK-MAPK-dependent signal transduction pathway mediates the stimulation of lysyl oxidase expression by serum and PDGF in rat aortic smooth muscle cells |
| Q41295028 | Quantitative polymerase chain reaction of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene. |
| Q34388063 | Retracted: Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma |
| Q56593725 | Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin |
| Q44220556 | The gene for lysyl oxidase maps to mouse chromosome 18. |
| Q24307235 | The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells |
| Q40531209 | The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. |
| Q34559457 | The role of copper in tumour angiogenesis |
Search more.